250 related articles for article (PubMed ID: 37894473)
1. Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment.
Lewis CR; Dadgar N; Yellin SA; Donnenberg VS; Donnenberg AD; Bartlett DL; Allen CJ; Wagner PL
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894473
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
Wei GX; Du Y; Zhou YW; Li LJ; Qiu M
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):851-861. PubMed ID: 36107723
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology and immunology of gastric cancer peritoneal metastasis.
Yao X; Ajani JA; Song S
Transl Gastroenterol Hepatol; 2020; 5():57. PubMed ID: 33073052
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
Roviello F; Caruso S; Neri A; Marrelli D
Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
[TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.
Wagner PL; Knotts CM; Donneberg VS; Dadgar N; Pico CC; Xiao K; Zaidi A; Schiffman SC; Allen CJ; Donnenberg AD; Bartlett DL
Ann Surg Oncol; 2024 Mar; 31(3):2069-2077. PubMed ID: 37996643
[TBL] [Abstract][Full Text] [Related]
7. Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy.
Kim S; Lee CM; Lee D; Kim JH; Park S; Park SH
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565463
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial.
Senthil M; Dayyani F
BMC Cancer; 2023 Mar; 23(1):209. PubMed ID: 36870941
[TBL] [Abstract][Full Text] [Related]
9. Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis.
Pesce S; Belgrano V; Greppi M; Carlomagno S; Squillario M; Barla A; Della Chiesa M; Di Domenico S; Mavilio D; Moretta L; Candiani S; Sivori S; De Cian F; Marcenaro E
Front Immunol; 2019; 10():1963. PubMed ID: 31497016
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies.
Chen C; Jung A; Yang A; Monroy I; Zhang Z; Chaurasiya S; Deshpande S; Priceman S; Fong Y; Park AK; Woo Y
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067366
[TBL] [Abstract][Full Text] [Related]
12. The current status of immunotherapy in peritoneal carcinomatosis.
Ströhlein MA; Heiss MM; Jauch KW
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1019-27. PubMed ID: 27530056
[TBL] [Abstract][Full Text] [Related]
13. Gastric adenocarcinoma peritoneal carcinomatosis: a narrative review.
Green BL; Davis JL
Dig Med Res; 2022 Jun; 5():. PubMed ID: 35815114
[TBL] [Abstract][Full Text] [Related]
14. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis.
Leiting JL; Grotz TE
World J Gastrointest Oncol; 2018 Oct; 10(10):282-289. PubMed ID: 30364780
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
Front Oncol; 2022; 12():939969. PubMed ID: 35847866
[TBL] [Abstract][Full Text] [Related]
17. Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
Bai R; Chen N; Liang T; Li L; Lv Z; Lv X; Cui J
Front Oncol; 2020; 10():912. PubMed ID: 32793461
[TBL] [Abstract][Full Text] [Related]
18. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
[TBL] [Abstract][Full Text] [Related]
19. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.
Goéré D; Gras-Chaput N; Aupérin A; Flament C; Mariette C; Glehen O; Zitvogel L; Elias D
BMC Cancer; 2014 Mar; 14():148. PubMed ID: 24589307
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.
Thomassen I; van Gestel YR; van Ramshorst B; Luyer MD; Bosscha K; Nienhuijs SW; Lemmens VE; de Hingh IH
Int J Cancer; 2014 Feb; 134(3):622-8. PubMed ID: 23832847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
